For the active immunisation of cattle to reduce clinical signs resulting from infection with infectious bovine rhinotracheitis (IBR) and to reduce virus excretion in infected animals the vaccine may be administed via the intranasal or the intramuscular route.

Legal Category:  POM-V

Bovilis IBR contains a living, avirulent strain of infectious bovine rhinotracheitis (IBR) virus.  For uses, dosage, contra-indications and warnings, see datasheet.  Bovilis IBR may only be prescribed and administered by your veterinary surgeon from whom advice should be sought.  Further information is available on request.